Bio Medica Lab

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BKA01015
  • NSEID: BMLL
  • BSEID:
INR
119.20
-5.6 (-4.49%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 453000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024

Compare Profit and Loss Results of Bio Medica Lab
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
38.00
107.00
-69.00
-64.49%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
38.00
107.00
-69.00
-64.49%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
19.00
74.00
-55.00
-74.32%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
7.00
-6.00
-85.71%
Operating Expenses
0.00
9.00
-9.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
22.00
89.00
-67.00
-75.28%
Operating Profit (PBDIT) excl Other Income
15.00
17.00
-2.00
-11.76%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
15.00
20.00
-5.00
-25.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
14.00
20.00
-6.00
-30.00%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
18.00
-5.00
-27.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
18.00
-5.00
-27.78%
Provision for Tax
3.00
4.00
-1.00
-25.00%
Profit After Tax
9.00
13.00
-4.00
-30.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
54.00
-50.00
-92.59%
Profit Available for appropriations
14.00
68.00
-54.00
-79.41%
Appropriations
14.00
68.00
-54.00
-79.41%
Equity Dividend (%)
0%
8%
-8.00
Earnings Per Share
10.67
10.47
0.20
1.91%
Profit And Loss - Net Sales
Net Sales 38.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024

Profit And Loss - Interest
Interest 1.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 9.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024